CII
NVO

Capital International Inc’s Novo Nordisk NVO Stock Holding History

Capital International Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.45M Hold
155,415
– – 0.05% 214
2026
Q1 		$5.71M Buy
155,415
+67,480
+77% +$3.2M 0.04% 225
2025
Q4 		$4.47M Sell
87,935
-145,643
-62% -$7.45M 0.04% 250
2025
Q3 		$13M Buy
233,578
+153,428
+191% +$8.98M 0.1% 181
2025
Q2 		$5.53M Buy
80,150
+23,029
+40% +$1.57M 0.05% 211
2025
Q1 		$3.97M Sell
57,121
-9,327
-14% -$770K 0.05% 222
2024
Q4 		$5.72M Buy
66,448
+15,514
+30% +$1.68M 0.07% 207
2024
Q3 		$6.06M Buy
50,934
+911
+2% +$121K 0.08% 201
2024
Q2 		$7.14M Buy
50,023
+4,579
+10% +$607K 0.1% 187
2024
Q1 		$5.84M Buy
45,444
+4,932
+12% +$587K 0.08% 198
2023
Q4 		$4.19M Buy
40,512
+14,566
+56% +$1.44M 0.07% 214
2023
Q3 		$2.36M Sell
25,946
-2,280
-8% -$201K 0.05% 230
2023
Q2 		$2.28M Buy
28,226
+6,754
+31% +$552K 0.04% 241
2023
Q1 		$1.71M Buy
21,472
+122
+0.6% +$8.65K 0.03% 228
2022
Q4 		$1.44M Sell
21,350
-564
-3% -$33.1K 0.03% 235
2022
Q3 		$1.09M Buy
21,914
+1,522
+7% +$81.5K 0.02% 254
2022
Q2 		$1.14M Buy
20,392
+16,032
+368% +$890K 0.02% 245
2022
Q1 		$242K Sell
4,360
-538
-11% -$27.6K ﹤0.01% 290
2021
Q4 		$274K Sell
4,898
-60
-1% -$3.25K ﹤0.01% 296
2021
Q3 		$238K Sell
4,958
-652
-12% -$31.5K ﹤0.01% 294
2021
Q2 		$235K Sell
5,610
-454
-7% -$17.6K ﹤0.01% 296
2021
Q1 		$204K Sell
6,064
-340
-5% -$12.1K ﹤0.01% 293
2020
Q4 		$224K Hold
6,404
– – ﹤0.01% 289
2020
Q3 		$222K Sell
6,404
-750
-10% -$25K ﹤0.01% 274
2020
Q2 		$234K Sell
7,154
-236
-3% -$7.53K ﹤0.01% 261
2020
Q1 		$222K Buy
7,390
+240
+3% +$7.15K ﹤0.01% 238
2019
Q4 		$207K Hold
7,150
– – ﹤0.01% 213
2019
Q3 		$185K Buy
+7,150
New +$181K ﹤0.01% 207
2017
Q1 		– Sell
-24,600
Closed -$441K – 166
2016
Q4 		$441K Buy
+24,600
New +$446K 0.05% 132

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Inc's NVO Position: Q2 2026 in Review

Capital International Inc held its Novo Nordisk (NVO) position steady in Q2 2026 at 155,415 shares worth $7.45M. The position accounts for 0.05% of the portfolio, ranked #214.

Capital International Inc first reported a position in NVO in Q4 2016 and has held it in 29 quarters since. The position peaked at $13M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Capital International Inc held 155,415 shares of Novo Nordisk worth $7.45M as of Q2 2026.
  • Capital International Inc left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.05% of Capital International Inc's portfolio in Q2 2026, its #214 holding.
  • Capital International Inc first reported a position in Novo Nordisk in Q4 2016 and has held it in 29 quarters since.
  • Capital International Inc's Novo Nordisk position peaked at $13M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.